1 Min Read
Nov 27 (Reuters) - Hikma Pharmaceuticals Plc:
* HIKMA PHARMACEUTICALS PLC - INVESTED IN BIOLINQ IN COLLABORATION WITH M VENTURES WHICH LED $10 MILLION SERIES A ROUND OF FINANCING Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.